Alexander M. Efanov

2.8k total citations
40 papers, 2.0k citations indexed

About

Alexander M. Efanov is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Alexander M. Efanov has authored 40 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Surgery, 19 papers in Molecular Biology and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Alexander M. Efanov's work include Pancreatic function and diabetes (33 papers), Metabolism, Diabetes, and Cancer (9 papers) and Cellular transport and secretion (7 papers). Alexander M. Efanov is often cited by papers focused on Pancreatic function and diabetes (33 papers), Metabolism, Diabetes, and Cancer (9 papers) and Cellular transport and secretion (7 papers). Alexander M. Efanov collaborates with scholars based in Sweden, United States and Russia. Alexander M. Efanov's co-authors include Jesper Gromada, Per‐Olof Berggren, Sabine Sewing, С. В. Зайцев, Martin Brenner, Heike Zitzer, Krister Bokvist, Marianne Høy, Iris Treinies and Anja Köster and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Alexander M. Efanov

39 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexander M. Efanov Sweden	23	1.2k	1.1k	469	270	264	40	2.0k
Susanne G. Straub United States	25	1.0k 0.8×	1.3k 1.2×	642 1.4×	310 1.1×	238 0.9×	41	1.9k
Iain Dukes United States	24	1.4k 1.1×	970 0.9×	294 0.6×	164 0.6×	202 0.8×	36	2.2k
Safia Costes France	21	732 0.6×	884 0.8×	456 1.0×	409 1.5×	374 1.4×	32	1.7k
Corentin Cras‐Méneur United States	22	1.1k 0.9×	1.3k 1.2×	525 1.1×	206 0.8×	491 1.9×	32	2.3k
Martin D. Meglasson United States	23	993 0.8×	1.1k 1.0×	583 1.2×	137 0.5×	311 1.2×	49	1.8k
Isabelle Leclerc United Kingdom	29	2.0k 1.6×	1.8k 1.7×	961 2.0×	167 0.6×	454 1.7×	63	3.0k
Myriam Nenquin Belgium	35	1.5k 1.2×	2.3k 2.1×	1.1k 2.3×	256 0.9×	399 1.5×	64	3.0k
Reshma Ramracheya United Kingdom	26	1.1k 0.9×	2.0k 1.9×	1.3k 2.8×	174 0.6×	391 1.5×	43	2.8k
Walter S. Zawalich United States	31	1.4k 1.1×	2.0k 1.9×	1.2k 2.6×	185 0.7×	352 1.3×	71	2.8k
Francesca Frigerio Switzerland	17	1.5k 1.3×	574 0.5×	259 0.6×	203 0.8×	672 2.5×	28	2.3k

Countries citing papers authored by Alexander M. Efanov

Since Specialization

Citations

This map shows the geographic impact of Alexander M. Efanov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander M. Efanov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander M. Efanov more than expected).

Fields of papers citing papers by Alexander M. Efanov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander M. Efanov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander M. Efanov. The network helps show where Alexander M. Efanov may publish in the future.

Co-authorship network of co-authors of Alexander M. Efanov

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander M. Efanov. A scholar is included among the top collaborators of Alexander M. Efanov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander M. Efanov. Alexander M. Efanov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Syed, Samreen K., et al.. (2025). Aggregated proinsulin in pancreatic β-cells is degraded by the autophagy pathway. Journal of Biological Chemistry. 301(3). 108257–108257. 1 indexed citations

Son, Jinsook, Hongxu Ding, Thomas B. Farb, et al.. (2021). BACH2 inhibition reverses β cell failure in type 2 diabetes models. Journal of Clinical Investigation. 131(24). 36 indexed citations

Song, Luyan, David G. Barrett, Karen L. Cox, et al.. (2020). A High-Throughput Assay for the Pancreatic Islet Beta-Cell Potassium Channel: Use in the Pharmacological Characterization of Insulin Secretagogues Identified from Phenotypic Screening. Assay and Drug Development Technologies. 19(1). 27–37. 2 indexed citations

Yu, Xiaopeng, Jill A. Willency, Keyun Qing, et al.. (2019). Long-Acting and Selective Oxytocin Peptide Analogs Show Antidiabetic and Antiobesity Effects in Male Mice. Journal of the Endocrine Society. 3(7). 1423–1444. 29 indexed citations

Ma, Wenzhen, Xingjuan Chen, Rok Cerne, et al.. (2018). Catechol estrogens stimulate insulin secretion in pancreatic β-cells via activation of the transient receptor potential A1 (TRPA1) channel. Journal of Biological Chemistry. 294(8). 2935–5880. 18 indexed citations

Lin, Hua, Alexander M. Efanov, Lisa S. Beavers, et al.. (2016). GPR142 Controls Tryptophan-Induced Insulin and Incretin Hormone Secretion to Improve Glucose Metabolism. PLoS ONE. 11(6). e0157298–e0157298. 57 indexed citations

Efanov, Alexander M., Martin Brenner, Alexei Kharitonenkov, et al.. (2006). Fibroblast Growth Factor-21 Improves Pancreatic β-Cell Function and Survival by Activation of Extracellular Signal–Regulated Kinase 1/2 and Akt Signaling Pathways. Diabetes. 55(9). 2470–2478. 417 indexed citations

Efanov, Alexander M., Iris Treinies, Heike Zitzer, et al.. (2005). The PDZ/coiled‐coil domain containing protein PIST modulates insulin secretion in MIN6 insulinoma cells by interacting with somatostatin receptor subtype 5. FEBS Letters. 579(28). 6305–6310. 12 indexed citations

Efanov, Alexander M., David G. Barrett, Martin Brenner, et al.. (2005). A Novel Glucokinase Activator Modulates Pancreatic Islet and Hepatocyte Function. Endocrinology. 146(9). 3696–3701. 106 indexed citations

10.

Efanov, Alexander M., Sabine Sewing, Krister Bokvist, & Jesper Gromada. (2004). Liver X Receptor Activation Stimulates Insulin Secretion via Modulation of Glucose and Lipid Metabolism in Pancreatic Beta-Cells. Diabetes. 53(suppl_3). S75–S78. 105 indexed citations

11.

Juhl, Kirstine, Marianne Høy, Hervør L. Olsen, et al.. (2003). cPLA₂α-evoked formation of arachidonic acid and lysophospholipids is required for exocytosis in mouse pancreatic β-cells. American Journal of Physiology-Endocrinology and Metabolism. 285(1). E73–E81. 29 indexed citations

12.

Gromada, Jesper, et al.. (2003). Restoration of First‐Phase Insulin Secretion by the Imidazoline Compound LY374284 in Pancreatic Islets of Diabetic db/db Mice. Annals of the New York Academy of Sciences. 1009(1). 332–340. 18 indexed citations

13.

Juhl, Kirstine, Alexander M. Efanov, Hervør L. Olsen, & Jesper Gromada. (2003). Secretory phospholipase A2 is released from pancreatic β-cells and stimulates insulin secretion via inhibition of ATP-dependent K+ channels. Biochemical and Biophysical Research Communications. 310(2). 274–279. 16 indexed citations

14.

Høy, Marianne, Pierre Maechler, Alexander M. Efanov, et al.. (2002). Increase in cellular glutamate levels stimulates exocytosis in pancreatic β‐cells. FEBS Letters. 531(2). 199–203. 64 indexed citations

15.

Sjöholm, Åke, Mikael Lehtihet, Alexander M. Efanov, et al.. (2002). Glucose Metabolites Inhibit Protein Phosphatases and Directly Promote Insulin Exocytosis in Pancreatic β-Cells. Endocrinology. 143(12). 4592–4598. 22 indexed citations

16.

Efanov, Alexander M., Marianne Høy, Robert Bränström, et al.. (2001). The Imidazoline RX871024 Stimulates Insulin Secretion in Pancreatic β-Cells from Mice Deficient in KATP Channel Function. Biochemical and Biophysical Research Communications. 284(4). 918–922. 14 indexed citations

17.

Efanov, Alexander M., С. В. Зайцев, Achim Raap, et al.. (2001). The Novel Imidazoline Compound BL11282 Potentiates Glucose-Induced Insulin Secretion in Pancreatic β-Cells in the Absence of Modulation of KATP Channel Activity. Diabetes. 50(4). 797–802. 51 indexed citations

18.

Efanov, Alexander M., Achim Raap, Ioulia B Efanova, et al.. (1999). Different Modes of Action of the Imidazoline Compound RX871024 in Pancreatic β‐Cells: Blocking of K⁺ Channels, Mobilization of Ca²⁺ from Endoplasmic Reticulum, and Interaction with Exocytotic Machinery^a. Annals of the New York Academy of Sciences. 881(1). 241–252. 20 indexed citations

19.

Зайцев, С. В., Mats Andersson, Alexander M. Efanov, et al.. (1998). An endogenous peptide isolated from the gut, NK‐lysin, stimulates insulin secretion without changes in cytosolic free Ca²⁺ concentration. FEBS Letters. 439(3). 267–270. 5 indexed citations

20.

Зайцев, С. В., Alexander M. Efanov, Ioulia B Efanova, et al.. (1996). Imidazoline Compounds Stimulate Insulin Release by Inhibition of KATP Channels and Interaction With the Exocytotic Machinery. Diabetes. 45(11). 1610–1618. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact